A detailed history of Ever Source Wealth Advisors, LLC transactions in Novavax Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 30 shares of NVAX stock, worth $260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 62 51.61%
Holding current value
$260
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$10.71 - $17.11 $342 - $547
-32 Reduced 51.61%
30 $0
Q2 2024

Aug 13, 2024

BUY
$3.89 - $20.97 $7 - $41
2 Added 3.33%
62 $0
Q4 2023

Feb 09, 2024

SELL
$4.8 - $7.67 $192 - $306
-40 Reduced 40.0%
60 $0
Q2 2023

Aug 04, 2023

BUY
$6.67 - $9.52 $667 - $952
100 New
100 $0
Q3 2022

Nov 07, 2022

BUY
$18.2 - $76.12 $6,169 - $25,804
339 New
339 $6,000
Q2 2022

Aug 01, 2022

SELL
$36.28 - $75.29 $616 - $1,279
-17 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$134.56 - $217.97 $2,287 - $3,705
17 New
17 $2,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.